Advances in the Therapy of Chronic Idiopathic Myelofibrosis

Advances in the Therapy of Chronic Idiopathic Myelofibrosis Cecilia Arana-Yi, Alfonso Quintás-Cardama, Francis Giles, Deborah Thomas, Antonio Carrasco-Yalan, Jorge Cortes, Hagop Kantarjian, Srdan Verstovsek Oncologist 2006; 11: 929-943 Author Information and Disclosures Target Audience: =AUD= Method of Physician Participation: Read course materials, complete course quiz and evaluation form. Learning Objectives After completing this course, the reader should be able to: Discuss the clinical manifestations of MMM and recent developments in the understanding of its pathogenesis. Discuss the most recent clinical trials involving novel therapies for MMM. Describe an algorithm-based approach to the treatment of patients with MMM. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Sep. 01, 2006 Most Recent Review: Sep. 01, 2006* Most Recent Update: Sep. 01, 2006 Date Credit Expires: Sep. 01, 2008 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.